Investing
Top Analyst Upgrades and Downgrades (BIDU, CPN, ID, M, MIR, OMCL, PLD, RFMD, RRI, SLXP, TWX, VRTX)
Published:
Last Updated:
These are Monday’s top analyst upgrades, downgrades, and initiations seen in Wall Street research calls:
Baidu, Inc. (NASDAQ: BIDU) Raised to Neutral at Credit Suisse.
Calpine Corp. (NYSE: CPN) Raised to Equal Weight at Barclays.
L-1 Identity Solutions (NYSE: ID) Cut to Underweight at JPMorgan.
Macy’s Inc. (NYSE: M) Cut to Hold at Deutsche Bank.
Mirant Corporation (NYSE: MIR) Cut to Underweight at Barclays.
Omnicall Inc. (NASDAQ: OMCL) Raised to Buy at ThinkEquity.
ProLogis (NYSE: PLD) Raised to Neutral at UBS.
RF Micro Devices (NASDAQ: RFMD) Started as Buy at Merriman Curhan Ford.
RRI Energy, Inc. (NYSE: RRI) Cut to Equal Weight at Barclays.
Salix Pharmaceuticals (NASDAQ: SLXP) Started as Buy at Jefferies.
Time Warner Inc. (NYSE: TWX) Raised to Buy at Benchmark.
Vertex Pharmaceuticals (NASDAQ: VRTX) Raised to Outperform at Oppenheimer.
You are invited to join our free daily email distribution list to hear about top analyst upgrades and downgrades, IPOs and secondary offerings, ongoing day trader and options trader alerts, stock and market rumors, Buffett and guru investor news, M&A and more.
JON C. OGG
FEBRUARY 1, 2010
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.